January 15, 2016
Traumeel and Heel would like to announce our presence at the 20th European Congress of Physical and Rehabilitation Medicine, organized by the European Society PRM (ESPRM) and the Portuguese Society PRM (SPMFR) that will be hosted in Estoril-Lisbon PORTUGAL from the 23rd – 29th of April 2016.
Heel is a sponsor of this important and exciting congress and Traumeel will be presented at a booth.
We look forward to welcoming you at our booth for a hopefully valuable and memorable exchange about Traumeel and what it can do for you and your patients.
Link to ESPRM 2016 website
June 11, 2015
Abstract on MOZArT (Management of Osteoarthritis of the Knee with Zeel® And Traumeel® Injections) published in the prestigious EULAR journal “Annals of the Rheumatic Diseases”
At the EULAR (Europ. League against Rheumatism) 2015 congress in Rome an abstract of the MOZArT study was published in the EULAR journal “Annals of the Rheumatic Diseases”.
The MOZArT study is a multi-center, double-blind, randomized placebo-controlled trial showing that combined intra-articular injections of Traumeel® and Zeel® T are an effective and safe first line injection treatment that reduces pain of osteoarthritis of the knee by more than 60% and has a comparable effect size to existing therapies.
Link to MOZArT osteoarthritis trial abstract